ConductScience.org, home

Paper41299751

Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer.

McGeagh L and 29 others. Trials, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer. Papers, record 41299751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41299751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer.
PubMed
Journal
Trials
PubMed
Year
2025
PubMed
Publication types
Journal Article, Clinical Trial Protocol
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-12-28
PubMed

Authors30

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McGeagh LLucyhttps://orcid.org/0000-0002-9226-5115
2Walker AAlice
3Hiller LLouise
4Dunn JJanet
5Wells MMary
6Donnelly PPeter
7Wardley AAndrew
8Wolstenholme JJane
9Horne RRobert
10Stewart SJSarah-Jane
11Brett JJo
12Cahir CCaitriona
13Fenlon DDeborah
14Rose JJan
15Turner LLesley
16Hughes LLyndsay
17Todd AAdam
18Nicholson BBrian
19Mawson PPhil
20Norris RRuth

Source PubMed

See all 30 authorsDownload CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, HormonalMajor topic
Breast NeoplasmsMajor topic
Medication AdherenceMajor topic
Female
Humans
Chemotherapy, Adjuvant
Cost-Benefit Analysis
Drug Costs
Neoplasm Staging
Patient-Centered Care
Pragmatic Clinical Trials as Topic
Quality of Life
Receptors, Estrogen
Time Factors
Treatment Outcome
United Kingdom
Randomized Controlled Trials as Topic

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NIHR200098National Institute for Health and Care ResearchPubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128052692Measuring illness representations in breast cancer survivors (BCS) prescribed tamoxifen: Modification and validation of the Revised Illness Perceptions Questionnaire (IPQ-BCS).Psychol Health2017https://conductscience.org/library/papers/28052692PubMed
223949153The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study.Br J Cancer2013https://conductscience.org/library/papers/23949153PubMed
325028218Cancer survivors' self-efficacy to self-manage in the year following primary treatment.J Cancer Surviv2015https://conductscience.org/library/papers/25028218PubMed
424312488Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework.PLoS One2013https://conductscience.org/library/papers/24312488PubMed
526211827Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.Lancet2015https://conductscience.org/library/papers/26211827PubMed
631823381The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence.Br J Clin Pharmacol2020https://conductscience.org/library/papers/31823381PubMed
737300986Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life.Breast2023https://conductscience.org/library/papers/37300986PubMed
829379627Psychometric properties of the Beliefs about Medicine Questionnaire-adjuvant endocrine therapy (BMQ-AET) for women taking AETs following early-stage breast cancer.Health Psychol Open2017https://conductscience.org/library/papers/29379627PubMed
917851765Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women.Breast Cancer Res Treat2008https://conductscience.org/library/papers/17851765PubMed
1028260867Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review.Patient Prefer Adherence2017https://conductscience.org/library/papers/28260867PubMed
1141421217Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me intervention.Eur J Oncol Nurs2026https://conductscience.org/library/papers/41421217PubMed
1223219286Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.Lancet2013https://conductscience.org/library/papers/23219286PubMed
1334593508A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance.BMJ2021https://conductscience.org/library/papers/34593508PubMed
1428276740Developing and validating a theoretical measure of modifiable influences on hormonal therapy medication taking behaviour in women with breast cancer.Psychol Health2017https://conductscience.org/library/papers/28276740PubMed
1524821365Self-efficacy for coping with symptoms moderates the relationship between physical symptoms and well-being in breast cancer survivors taking adjuvant endocrine therapy.Support Care Cancer2014https://conductscience.org/library/papers/24821365PubMed
168445433The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.J Clin Oncol1993https://conductscience.org/library/papers/8445433PubMed
1722689091Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.Breast Cancer Res Treat2012https://conductscience.org/library/papers/22689091PubMed
1838240343Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews.Cancer Med2024https://conductscience.org/library/papers/38240343PubMed
1921802721Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.Lancet2011https://conductscience.org/library/papers/21802721PubMed
2029083951Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review.J Biopharm Stat2018https://conductscience.org/library/papers/29083951PubMed

See all 40 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42580839Supporting adherence to adjuvant CDK4/6 inhibitors in women with early breast cancer (SWEET-PLUS): protocol for a multicentre UK study using qualitative and co-development methods.BMJ Open2026https://conductscience.org/library/papers/42580839PubMed
42358822Emerging Approaches in Breast Cancer: From Molecular Mechanisms to Diagnosis and Therapeutic Strategies.Oncol Res2026https://conductscience.org/library/papers/42358822PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41299751

GET https://conductscience.org/api/papers/v1/41299751/authors?page=2